• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery.

作者信息

Pontes João Paulo Jordão, de Melo Caroline Souto, Arantes Flávia Bittar Britto, de Souza Ramos Juan Thomaz Gabriel, Módolo Norma Sueli Pinheiro, Navarro E Lima Laís Helena

机构信息

Department of Anesthesiology, Complexo Hospitalar Santa Genoveva de Uberlândia, Minas Gerais, Brazil.

Department of Anesthesiology, Complexo Hospitalar Santa Genoveva de Uberlândia, Minas Gerais, Brazil.

出版信息

J Clin Anesth. 2021 Aug;71:110201. doi: 10.1016/j.jclinane.2021.110201. Epub 2021 Feb 26.

DOI:10.1016/j.jclinane.2021.110201
PMID:33647525
Abstract
摘要

相似文献

1
Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery.心脏手术后使用SGLT-2抑制剂后发生的围手术期正常血糖性糖尿病酮症酸中毒
J Clin Anesth. 2021 Aug;71:110201. doi: 10.1016/j.jclinane.2021.110201. Epub 2021 Feb 26.
2
Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.恩格列净治疗的 2 型糖尿病患者发生多因素病因的严重血糖正常性糖尿病酮症酸中毒：病例报告及文献复习。
BMC Nephrol. 2020 Jul 15;21(1):276. doi: 10.1186/s12882-020-01930-6.
3
Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.SGLT2 抑制剂治疗的 2 型糖尿病患者出现血糖水平低于预期的糖尿病酮症酸中毒的易感因素：综述。
Eur J Clin Pharmacol. 2021 May;77(5):651-657. doi: 10.1007/s00228-020-03051-3. Epub 2020 Nov 26.
4
Dapagliflozin-Associated Diabetic Ketoacidosis.达格列净相关的糖尿病酮症酸中毒
Am J Ther. 2018 Nov/Dec;25(6):e765-e766. doi: 10.1097/MJT.0000000000000770.
5
Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.使用钠-葡萄糖协同转运蛋白2抑制剂治疗的2型糖尿病患者中的正常血糖性糖尿病酮症酸中毒
Can Fam Physician. 2016 Sep;62(9):722-4.
6
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors.与2型钠-葡萄糖协同转运蛋白抑制剂相关的正常血糖性糖尿病酮症酸中毒
Med Clin (Barc). 2024 Jul 26;163(2):101-102. doi: 10.1016/j.medcli.2024.01.025. Epub 2024 Apr 26.
7
Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment.血糖正常的糖尿病酮症酸中毒作为 SGLT-2 抑制剂的并发症：流行病学、病理生理学和治疗。
Expert Opin Drug Saf. 2020 Jun;19(6):673-682. doi: 10.1080/14740338.2020.1764532. Epub 2020 Jun 10.
8
Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors After Cardiac Surgery: A Review of Current Literature.心脏手术后与钠-葡萄糖协同转运蛋白2抑制剂相关的正常血糖性糖尿病酮症酸中毒：当前文献综述
J Cardiothorac Vasc Anesth. 2022 Oct;36(10):3877-3886. doi: 10.1053/j.jvca.2022.06.008. Epub 2022 Jun 16.
9
Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.恩格列净所致酮症酸中毒：一种范式转变——病例报告及文献综述
Curr Diabetes Rev. 2019;15(4):259-262. doi: 10.2174/1573399814666180726114044.
10
Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.2型钠-葡萄糖协同转运蛋白抑制剂：应对糖尿病酮症酸中毒这一虽小但关键的风险
Med J Aust. 2021 Feb;214(2):94-94.e1. doi: 10.5694/mja2.50898. Epub 2020 Dec 21.

引用本文的文献

1
Euglycemic Diabetic Ketoacidosis in a Patient with Type 2 Diabetes and Preserved Insulin Secretion on Empagliflozin.一名2型糖尿病患者在使用恩格列净时出现血糖正常的糖尿病酮症酸中毒且胰岛素分泌功能保留
Intern Med. 2025 Jul 15;64(14):2183-2188. doi: 10.2169/internalmedicine.4752-24. Epub 2025 Apr 26.
2
[Position statement: surgery and diabetes mellitus (Update 2023)].[立场声明：外科手术与糖尿病（2023年更新版）]
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):256-271. doi: 10.1007/s00508-022-02121-z. Epub 2023 Apr 20.
3
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports.
钠-葡萄糖共转运蛋白 2 抑制剂相关围手术期酮症酸中毒：病例报告的系统评价。
J Anesth. 2023 Jun;37(3):465-473. doi: 10.1007/s00540-023-03174-8. Epub 2023 Feb 27.
4
SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.钠-葡萄糖协同转运蛋白 2 抑制剂与 FAERS 中的血糖正常糖尿病酮症酸中毒/糖尿病酮症酸中毒：一项药物警戒评估。
Acta Diabetol. 2023 Mar;60(3):401-411. doi: 10.1007/s00592-022-02015-6. Epub 2022 Dec 28.
5
New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature.新型糖尿病药物钠-葡萄糖协同转运蛋白2抑制剂可诱发正常血糖性酮症酸中毒并酷似外科疾病：一例报告及文献复习
Front Surg. 2022 Mar 24;9:828649. doi: 10.3389/fsurg.2022.828649. eCollection 2022.
6
Euglycemic Diabetic Ketoacidosis in a Sedated Patient after Coronary Artery Bypass Grafting: A Case Report and Literature Review.冠状动脉搭桥术后镇静患者的正常血糖性糖尿病酮症酸中毒：一例报告及文献综述
Case Rep Med. 2021 Nov 18;2021:2086520. doi: 10.1155/2021/2086520. eCollection 2021.
7
Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction.钠-葡萄糖共转运蛋白 2 抑制剂致射血分数保留的心力衰竭伴血糖正常的糖尿病酮症酸中毒。
ESC Heart Fail. 2021 Aug;8(4):2631-2636. doi: 10.1002/ehf2.13452. Epub 2021 Jun 8.